{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:14:41Z","timestamp":1785420881188,"version":"3.56.0"},"reference-count":41,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet. World"],"published-print":{"date-parts":[[2026,1,31]]},"abstract":"<jats:p>Background and Aim: Topical nonsteroidal anti-inflammatory drugs are commonly used in feline ophthalmology, especially for long-term management of uveitis after cataract surgery. However, there is very limited data on how they affect the feline ocular surface, particularly the conjunctival tissue, goblet cell density (GCD), meibomian glands (MGs), and oxidative stress. This study assessed whether 15-day, thrice-daily application of 0.45% preservative-free ketorolac tromethamine (FKT) or 0.4% benzalkonium chloride (BAC)\u2013preserved ketorolac tromethamine (BACKT) influences ocular surface disease scores, tear film parameters, GCD, MG morphology, matrix metalloproteinase-9 (MMP-9), and oxidative stress biomarkers (OSB) in healthy cats. \n\nMaterials and Methods: A prospective, randomized, double-masked, crossover design was used with 13 healthy cats. Each cat received FKT in one eye and BACKT in the other eye every 8 h for 15 days, followed by a 3-week washout period and reversal of treatment. A separate control group (CG; n=13) received topical saline. Clinical assessments included conjunctival hyperemia, blepharospasm, Schirmer tear test (STT), tear film break-up time (TFBT), lissamine green, and fluorescein staining. Meibography was used to quantify MG loss. Conjunctival biopsies obtained at baseline and day 15 were analyzed for GCD, MMP-9, superoxide dismutase, catalase, reduced glutathione, and malondialdehyde levels. \n\nResults: No groups showed corneoconjunctival staining or conjunctival hyperemia at any point. Mild blepharospasm developed in 3 out of 13 FKT-treated eyes and 9 out of 13 BACKT-treated eyes (p = 0.003). STT values significantly decreased from baseline to day 15 in both FKT and BACKT groups (p &lt; 0.05). TFBT decreased significantly only in FKT-treated eyes (p = 0.009), although BACKT showed a similar, non-significant trend. MG loss increased significantly only in BACKT-treated eyes (p = 0.04). GCD decreased markedly in both FKT (p = 0.0003) and BACKT (p &lt; 0.0001) groups and was lower than CG at day 15. OSB remained largely unchanged, except for higher MDA levels in BACKT-treated eyes compared with CG (p = 0.04). MMP-9 expression did not differ within or between groups. \n\nConclusion: Both ketorolac formulations reduced STT, TFBT, and GCD, supporting the development of a qualitative dry eye state in healthy cats. BACKT resulted in greater ocular discomfort, increased MG loss, and higher lipid peroxidation, indicating BAC-related cytotoxicity. Caution is advised when prescribing prolonged topical ketorolac, and concurrent ocular lubrication is recommended. \n\nKeywords: benzalkonium chloride, feline ophthalmology, goblet cell density, Ketorolac tromethamine, matrix metalloproteinase-9, meibomian gland loss, ocular surface disease, oxidative stress biomarkers, Schirmer tear test, tear film break-up time.<\/jats:p>","DOI":"10.14202\/vetworld.2026.310-323","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:38:23Z","timestamp":1769413103000},"page":"310","update-policy":"https:\/\/doi.org\/10.14202\/vetworld.2022.policies","source":"Crossref","is-referenced-by-count":0,"title":["Fifteen-day topical ketorolac tromethamine, with and without benzalkonium chloride, alters tear function, goblet cell density, and meibomian gland integrity in healthy cats"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-5709","authenticated-orcid":false,"given":"Bruna Carvalho","family":"Silveira","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-2886","authenticated-orcid":false,"given":"Alexandre Pinto","family":"Ribeiro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-5938","authenticated-orcid":false,"given":"Matheus Anthony","family":"Mendes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5725-3665","authenticated-orcid":false,"given":"Maria Gabriela de Mendon\u00e7a","family":"Mazetti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-1748","authenticated-orcid":false,"given":"Douglas Lisboa","family":"Ramalho","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-380X","authenticated-orcid":false,"given":"Anderson Oliveira","family":"Souza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-9073","authenticated-orcid":false,"given":"Nathalia de Assis","family":"Pereira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9456-7735","authenticated-orcid":false,"given":"Natali\u00ea","family":"Ecker","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01mqvjv41","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade Federal de Mato Grosso"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5308","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tHsu KK, Pinard CL, Johnson RJ, Allen DG, KuKanich BK, Nykamp SG. Systemic absorption and adverse ocular and systemic effects after topical ophthalmic administration of 0.1% diclofenac to healthy cats. Am J Vet Res. 2015;76(3):253\u2013265.","DOI":"10.2460\/ajvr.76.3.253"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tRoberts JK, Meekins JM, Roush JK, Rankin AJ. Effects of topical instillation of 0.1% diclofenac sodium, 0.5% ketorolac tromethamine, and 0.03% flurbiprofen sodium on corneal sensitivity in ophthalmologically normal cats. Am J Vet Res. 2021;82(1):81\u201387.","DOI":"10.2460\/ajvr.82.1.81"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tMiranda HR, Ribeiro AP, Pizzinatto FD, Rodrigues BE, Assis Pereira N, Oliveira Alves TH, et al. Effects of loteprednol etabonate and ketorolac tromethamine on intraocular inflammation and oxidative stress after paracentesis-induced blood\u2013aqueous barrier breakdown in cats. Vet Ophthalmol. 2025 Apr 17.","DOI":"10.1111\/vop.70020"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tGoldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36:361\u2013368.","DOI":"10.1038\/s41433-021-01668-x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tHendrix DV, Ward DA, Barnhill MA. Effects of antiinflammatory drugs and preservatives on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture. Vet Ophthalmol. 2002;5:127\u2013135.","DOI":"10.1046\/j.1463-5224.2002.00218.x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tAyaki M, Iwasawa A, Soda M, Yaguchi S, Koide R. Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. Clin Ophthalmol. 2010;4:1019\u20131024.","DOI":"10.2147\/OPTH.S12452"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tSonego DA, Ribeiro AP, Dower NMB, Rodrigues BE, Fran\u00e7a Lemes SA, Oliveira Souza A, et al. Effects of topical ketorolac tromethamine on tear parameters, meibography, goblet cell density, and conjunctival oxidative stress in healthy dogs. Vet Ophthalmol. 2024;27(3):214\u2013227.","DOI":"10.1111\/vop.13177"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tRigas B, Huang W, Honkanen R. NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation. Surv Ophthalmol. 2020;65:1\u201311.","DOI":"10.1016\/j.survophthal.2019.07.001"},{"key":"ref8","unstructured":"9.\tChu YR, Sell M. Clinical evaluation of ocular surface toxicity of ketorolac tromethamine 0.4% (Acular LS\u00ae) vs bromfenac 0.09% (Xibrom\u00ae) ophthalmic solution. Invest Ophthalmol Vis Sci. 2006;47:74."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tPetznick A, Madigan MC, Garrett Q, Sweeney DF, Evans MD. Contributions of ocular surface components to matrix-metalloproteinases-2 and -9 in feline tears following corneal epithelial wounding. PLoS One. 2013;8(8):e71948.","DOI":"10.1371\/journal.pone.0071948"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tPizzinatto FD, Ribeiro AP, Silveira BC, Lobo PM, Miranda HR, Nathalia N. Induced corneal ulcers in cats: effects of 2% dorzolamide on epithelization time and on the expression of matrix metalloproteinase-9. Acta Sci Vet. 2023;51:1911.","DOI":"10.22456\/1679-9216.126408"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tReviglio V.E., Rana T.S., Li Q.J., Ashraf M.F., Daly M.K. and O'Brien T.P. (2003) Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. J. Cataract Refract. Surg. 29(5):989\u2013997.","DOI":"10.1016\/S0886-3350(02)01737-6"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tLima TB, Ribeiro AP, Concei\u00e7\u00e3o LF, Bandarra M, Manrique WG, Laus JL. Ketorolac eye drops reduce inflammation and delay re-epithelization in response to corneal alkali burn in rabbits, without affecting iNOS or MMP-9. Arq Bras Oftalmol. 2015;78:67\u201372.","DOI":"10.5935\/0004-2749.20150019"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tDemir U, Demir T, Ilhan N. The protective effect of alpha-lipoic acid against oxidative damage in rabbit conjunctiva and cornea exposed to ultraviolet radiation. Ophthalmologica. 2005;219:49\u201353.","DOI":"10.1159\/000081783"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tChen BY, Lin DP, Chang LS, Huang TP, Liu HJ, Luk CP, et al. Dietary \u03b1-lipoic acid prevents UVB-induced corneal and conjunctival degeneration through multiple effects. Invest Ophthalmol Vis Sci. 2013;54:6757\u20136766.","DOI":"10.1167\/iovs.12-10891"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tRuban VV, Anbukkarasi M, Anand T, Thomas PA, Geraldine P. Oxidative stress in corneal tissue in experimental keratitis due to Aspergillus flavus: effect of topical voriconazole therapy. Biocatal Agric Biotechnol. 2019;21:101323.","DOI":"10.1016\/j.bcab.2019.101323"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tKojima T, Dogru M, Ibrahim OM, Wakamtsu TH, Ito M, Igarashi A, et al. Effects of oxidative stress on the conjunctiva in Cu,Zn-superoxide dismutase-1 knockout mice. Invest Ophthalmol Vis Sci. 2015;56:8382\u20138391.","DOI":"10.1167\/iovs.15-18295"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tSedlak L, \u015awierczy\u0144ska M, Borymska W, Zych M, Wygl\u0119dowska-Promie\u0144ska D. Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film. BMC Ophthalmol. 2021;21:319.","DOI":"10.1186\/s12886-021-02079-y"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.\tFarghali HA, AbdElKader NA, AbuBakr HO, Ramad\u00e3 ES, Khattab MS, Salem N, et al. Corneal ulcer in dogs and cats: novel clinical application of regenerative therapy using subconjunctival injection of autologous platelet-rich plasma. Front Vet Sci. 2021;8:641265.","DOI":"10.3389\/fvets.2021.641265"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tHsueh YJ, Chen YN, Tsao YT, Cheng CM, Wu WC, Chen HC. The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases. Int J Mol Sci. 2022;23:1255.","DOI":"10.3390\/ijms23031255"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.\tFenollosa-Romero E, Jeanes E, Freitas I, et al. Outcome of phacoemulsification in 71 cats: a multicenter retrospective study (2006\u20132017). Vet Ophthalmol. 2020;23:141\u2013147.","DOI":"10.1111\/vop.12699"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.\tBailey K, Webb T. Retrospective study of long-term outcome of phacoemulsification in 22 feline eyes with presumed congenital\/juvenile cataracts (2007\u20132020). J Am Anim Hosp Assoc. 2022;58(3):121\u2013128.","DOI":"10.5326\/JAAHA-MS-7201"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tDi Pietro S, Tabb\u00ec M, Falcone A, Macri F, Piccione G, Giudice E, et al. Hospitalization disrupts the daily rhythm of tear production in cats. Vet Ophthalmol. 2023;26:119\u2013124.","DOI":"10.1111\/vop.13037"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tSebbag L, Uhl LK, Schneider B, Hayes B, Olds J, Mochel JP. Investigation of Schirmer tear test-1 for measurement of tear production in cats in various environmental settings and with different test durations. J Am Vet Med Assoc. 2020;256(6):681\u2013686.","DOI":"10.2460\/javma.256.6.681"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.\tIwashita H, Sebbag L, Leonard BC, Saito A. A review of diagnostic tests for qualitative and quantitative tear film deficiency in dogs. Vet Ophthalmol. 2023;26(Suppl 1):5\u201315.","DOI":"10.1111\/vop.13044"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tSebbag L, Reilly CM, Eid R, Maggs DJ. Goblet cell density and distribution in cats with clinically and histologically normal conjunctiva. Vet Ophthalmol. 2016;19(Suppl 1):38\u201343.","DOI":"10.1111\/vop.12343"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tEwing JF, Janero DR. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem. 1995;232:243\u2013248.","DOI":"10.1006\/abio.1995.0014"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.\tAebi H. Catalase in vitro. Methods Enzymol. 1984;105:121\u2013126.","DOI":"10.1016\/S0076-6879(84)05016-3"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.\tHissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976;74:214\u2013226.","DOI":"10.1016\/0003-2697(76)90326-2"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tPerc\u00e1rio S. Prevention of oxidative stress in renal ischemia reperfusion syndrome in rats with nutritional antioxidant supplementation. Rev Nutr. 2010;23:259\u2013267.","DOI":"10.1590\/S1415-52732010000200009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.\tSebbag L, Kass PH, Maggs DJ. Reference values, interest correlations, and test-retest repeatability of selected tear film tests in healthy cats. J Am Vet Med Assoc. 2015;246:426\u2013435.","DOI":"10.2460\/javma.246.4.426"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.\tKawahara A, Utsunomiya T, Kato Y, Takayanagi Y. Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: randomized trial. Clin Ophthalmol. 2016;10:385\u2013391.","DOI":"10.2147\/OPTH.S101836"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.\tKim Y, Kang S, Kim S, Shim J, Go S, Seo K. Reference values for selected dry eye tests in normal beagle dogs: a pilot study. J Vet Sci. 2022;23:e10.","DOI":"10.4142\/jvs.21169"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.\tNg ATJ, Moore PA, Boveland SD. Assessment of meibomian gland morphology and tear-film lipid layer using noncontact infrared meibography and meibometry, respectively, and tear-film osmolarity in healthy dogs. Vet Ophthalmol. 2024 Nov 11.","DOI":"10.1111\/vop.13294"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tMalmin A, Thomseth VM, F\u00f8rland PT, Khan AZ, Hetland HB, Chen X, et al. Associations between serial intravitreal injections and dry eye. Ophthalmology. 2023;130(5):509\u2013515.","DOI":"10.1016\/j.ophtha.2023.01.009"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tE\u00f6rd\u00f6gh R, Jakab C, Papp R, Tichy A, Nell B. Density and distribution of feline conjunctival goblet cells. J Feline Med Surg. 2017;19(10):1048\u20131054.","DOI":"10.1177\/1098612X16673000"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.\tKato K, Miyake K, Kondo N, Asano S, Takeda J, Takahashi A, et al. Conjunctival goblet cell density following cataract surgery with diclofenac versus diclofenac and rebamipide: randomized trial. Am J Ophthalmol. 2017;181:26\u201331.","DOI":"10.1016\/j.ajo.2017.06.016"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.\tMac\u00edas SDCG, Jauregui Franco RO, Torres-Arellano JM, Gallegos YC, Espinosa JMM, R\u00edos AS, et al. Effects of ophthalmic medications on conjunctival goblet cell density in New Zealand white rabbits. Biomed Hub. 2025;10(1):64\u201371.","DOI":"10.1159\/000544102"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.\tFan X, Monnier VM, Whitson J. Lens glutathione homeostasis: discrepancies and gaps in knowledge standing in the way of novel therapeutic approaches. Exp Eye Res. 2017;156:103\u2013111.","DOI":"10.1016\/j.exer.2016.06.018"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40.\tTomsi\u010d K, Domanjko Petri\u010d A, Nemec A, Pirman T, Rezar V, Sliskar A, et al. Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1. Front Vet Sci. 2023;10:1203480.","DOI":"10.3389\/fvets.2023.1203480"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tLi S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 2015;16(11):26087\u201326124.","DOI":"10.3390\/ijms161125942"}],"container-title":["Veterinary World"],"original-title":[],"link":[{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/January-2026\/22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:38:32Z","timestamp":1769413112000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/January-2026\/22.php"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":41,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2026.310-323","relation":{},"ISSN":["0972-8988","2231-0916"],"issn-type":[{"value":"0972-8988","type":"print"},{"value":"2231-0916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"article-number":"22"}}